Fooyin University
Kaohsiung City, Taiwan
Location status: Recruiting
NCT Number: NCT06898073
The purpose of this study is to explore the effects of curved walking training under dual-task conditions on the cognitive function and walking ability of stroke patients.
Interested in participating?
Request Info40 year–80 year
All sexes
Interventional
Not applicable
Kaohsiung City, Taiwan
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cognitive tasks as the second task in addition to walking
walking without performing a second task during the walking training
Time frame: From baseline to the end of treatment at 3 weeks
Mini-Mental State Examination (MMSE) includes items such as orientation, attention, memory, language, verbal comprehension, executive function, and construction ability. The maximum score is 30 points. A higher score indicates better cognitive function. One point is given for each correct answer. A total score below 24 suggests mild cognitive impairment, while a score below 16 indicates severe cognitive impairment.
Time frame: From baseline to the end of treatment at 3 weeks
The test consists of two parts, A and B. In part A, the participant is asked to connect a series of numbers in sequential order as quickly as possible. Part B includes both numbers and colors, where the participant must alternate between connecting the numbers and colors in order. The test records the time taken to complete the sequence and the number of errors made for scoring. If part B is not completed within 5 minutes, the test is stopped, and the highest score of 300 seconds is recorded. A lower score indicates faster completion time, suggesting better function.
Time frame: From baseline to the end of treatment at 3 weeks
The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. The time (seconds) taken to turn will be recorded using a stopwatch.
Time frame: From baseline to the end of treatment at 3 weeks
The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. The numbers of steps taken to turn will be recorded using a counter.
Time frame: From baseline to the end of treatment at 3 weeks
The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. Gait speed (m/s) will be recorded using the commercially available portable gait analysis system (Gait Up).
Time frame: From baseline to the end of treatment at 3 weeks
The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. Step length (cm) during gait will be recorded and analyzed using the commercially available portable gait analysis system (Gait Up).
Time frame: From baseline to the end of treatment at 3 weeks
The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. Step time (seconds) will be recorded and analyzed using the commercially available portable gait analysis system (Gait Up).
Time frame: From baseline to the end of treatment at 3 weeks
The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. The time taken to turn will be recorded using a stopwatch.
Time frame: From baseline to the end of treatment at 3 weeks
The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. The numbers of steps taken to turn will be recorded using a counter.
Time frame: From baseline to the end of treatment at 3 weeks
The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. Gait speed will be recorded using the commercially available portable gait analysis system (Gait Up).
Time frame: From baseline to the end of treatment at 3 weeks
The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. Step length (cm) will be recorded using the commercially available portable gait analysis system (Gait Up).
Time frame: From baseline to the end of treatment at 3 weeks
The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. Step time (second) will be recorded using the commercially available portable gait analysis system (Gait Up).
Time frame: From baseline to the end of treatment at 3 weeks
This test requires a 3-meter distance to be marked on the floor, with a chair placed at one end. The time which the participant stands up, walks forward to the 3-meter mark, turns around, walks back to the chair, and sits down again will be calculated and recorded.
Time frame: From baseline to the end of treatment at 3 weeks
The figure-eight walking test path includes both straight and turning paths. The participant will first be asked to stand between two traffic cones, spaced 5 feet apart. They will then be instructed to walk forward, turn around the first cone in their preferred direction, return to the starting point, and then turn around the second cone in the opposite direction before returning to the center. The time taken to complete the figure-eight walking test will be recorded.
Time frame: From baseline to the end of treatment at 3 weeks
The figure-eight walking test path includes both straight and turning paths. The participant will first be asked to stand between two traffic cones, spaced 5 feet apart. They will then be instructed to walk forward, turn around the first cone in their preferred direction, return to the starting point, and then turn around the second cone in the opposite direction before returning to the center. Numbers of steps to complete the Figure-of-Eight Walk test will be recorded.
Time frame: From baseline to the end of treatment at 3 weeks
This scale includes 14 test items. The scoring for each item ranges from 0 to 4. Generally, a score of 0 means the participant is completely unable to perform the test, while a score of 4 means the participant can complete the action within the specified time or achieve the maximum required distance or range of motion for the task. Each test item has a clear description of the scoring criteria. The total score is 56, and a higher score indicates better balance ability.
Time frame: From baseline to the end of treatment at 3 weeks
This is a questionnaire that assesses the participant's level of self-confidence in maintaining balance in 16 situations commonly encountered in the community. Each of the 16 items is scored starting from 0, where 0 indicates no confidence, and scores increase in intervals of 10, with a maximum score of 100. A score of 100 represents complete confidence in maintaining balance.
Time frame: From baseline to the end of treatment at 3 weeks
The number of falls experienced by the participant in the past year will first be recorded. The participant will then be provided with a fall diary to track the number of falls during the one-year follow-up period after the assessment. In this study, a fall is defined as when the individual unintentionally falls to the ground, floor, or another lower level position. Each month, a follow-up phone call will be made to ensure the participant is recording the fall count as required.
Contact information is provided by the study sponsor or research team.
Fooyin University
Other
Effects of Dual-task Training During Curved Walking for Cognitive Function in Stroke Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07661849
Brain Diseases, Cardiovascular Diseases
El Paso, Texas, United States
View Trial DetailsNCT07642154
Brain Diseases, Cardiovascular Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07565363
Brain Diseases, Cardiovascular Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04682223
Aphasia, Brain Diseases
Columbia, South Carolina, United States
View Trial Details